Dr. Georges Jabre, the recently appointed CEO of Serdia Pharmaceuticals (India) Pvt. Ltd. (an affiliate of the Servier Group) and president of the Healthcare Committee of the Indo-French Chamber of Commerce and Industry (IFCCI), provides insights into some key specificities of India’s healthcare ecosystem as well as his main priorities in both roles.
You honed an extensive experience covering the Middle East and African markets for Servier prior to taking over the company’s operations in India in October 2017. What are the similarities you identify between these regions, as well as the skills gained when operating in the Middle East and Africa which could reveal themselves precious in India?
"...despite the population´s rising expectations, Indian doctors are doing their utmost to be close to their patients, although doctors’ incomes in India are lower than those of many of their international counterparts."
